Home › Bayer clotting drug meets late-stage study's goal
 

Keywords :   


Bayer clotting drug meets late-stage study's goal

2014-02-19 03:22:29| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals said Tuesday that its experimental, genetically engineered treatment for the most common type of bleeding disorder hemophilia met its main goal of reducing treatment frequency in a late-stage patient study.

Tags: goal drug meets bayer

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »